Who owns the FAX PHARMA trademark?

The FAX PHARMA trademark is owned by Fax Pharma Inc..

What class is the FAX PHARMA trademark registered in?

The FAX PHARMA trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for FAX PHARMA?

The USPTO serial number for FAX PHARMA is 88983690.

What is the registration number for FAX PHARMA?

FAX PHARMA is registered under USPTO registration number 6673026.

Sealvo

Home Search: FAX PHARMAFAX PHARMA #88983690

Back

Updated Sep 27, 2026·35 searches this week

View on USPTO TSDR Find similar marks

FAX

USPTO Trademark Record

REGISTERED

FAX PHARMA

SN 88983690·Reg 6673026·Filed Jan 28, 2020

Owner Fax Pharma Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

FAX PHARMA (Serial No. 88983690), Registration No. 6673026, is a registered US trademark filed on Jan 28, 2020 by Fax Pharma Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: March 15, 2028

Conflict Analysis

Full conflict analysis for FAX PHARMA (SN 88983690) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

FAX PHARMA (Reg. #6673026) is a registered US trademark that has been protecting its owner, Fax Pharma Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 28, 2020

SERIAL

88983690

REG#

6673026

REGISTERED

Mar 15, 2022

Filing Information

StatusREGISTERED

Filing DateJan 28, 2020

Serial Number88983690

Registration No.6673026

Registration DateMar 15, 2022

Status DateMar 15, 2022

Published for OppositionApr 27, 2021

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Jun 19, 2019

First use in commerce: Aug 19, 2019

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

40 events

REGISTERED-PRINCIPAL REGISTER

Mar 15, 2022

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 08, 2022

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 07, 2022

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

STATEMENT OF USE PROCESSING COMPLETE

Jan 20, 2022

STATEMENT OF USE PROCESSING COMPLETE

DIVISIONAL PROCESSING COMPLETE

Jan 20, 2022

DIVISIONAL PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jan 07, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Dec 22, 2021

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 22, 2021

USE AMENDMENT FILED

DIVISIONAL REQUEST RECEIVED

Dec 22, 2021

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Dec 22, 2021

TEAS REQUEST TO DIVIDE RECEIVED

POST PUBLICATION AMENDMENT - ENTERED

Jul 02, 2021

POST PUBLICATION AMENDMENT - ENTERED

ASSIGNED TO PETITION STAFF

Jul 01, 2021

ASSIGNED TO PETITION STAFF

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 22, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

TEAS POST PUBLICATION AMENDMENT RECEIVED

May 27, 2021

TEAS POST PUBLICATION AMENDMENT RECEIVED

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 27, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Apr 27, 2021

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 07, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 19, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 18, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Mar 17, 2021

ASSIGNED TO LIE

FINAL REFUSAL E-MAILED

Mar 08, 2021

FINAL REFUSAL E-MAILED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 08, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 08, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

FINAL REFUSAL WRITTEN

Mar 08, 2021

FINAL REFUSAL WRITTEN

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 18, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 18, 2021

ASSIGNED TO LIE

PETITION TO REVIVE-GRANTED

Nov 25, 2020

PETITION TO REVIVE-GRANTED

NOTICE OF REVIVAL - E-MAILED

Nov 25, 2020

NOTICE OF REVIVAL - E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 25, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

TEAS PETITION TO REVIVE RECEIVED

Nov 25, 2020

TEAS PETITION TO REVIVE RECEIVED

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Nov 16, 2020

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 16, 2020

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

NON-FINAL ACTION WRITTEN

Apr 23, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Apr 23, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 23, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 16, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 03, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 31, 2020

NEW APPLICATION ENTERED

Other Marks by Fax Pharma Inc.

Additional USPTO filings from the same owner.

FAX

FAX PHARMA

88776508

Fax Pharma Inc.

REGISTERED

FAX

FAX PHARMA

88776515

Fax Pharma Inc.

REGISTERED

FAX

FAX PHARMA

88983683

Fax Pharma Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

FAX

FAX PHARMA

88983683

Fax Pharma Inc.

REGISTERED

PHA

PHARMA &

90800714

PHARMAAND GMBH

REGISTERED

FAX

FAX@VANTAGE

87097601

Applied Systems, Inc.

REGISTERED

XMF

XM FAX

88116332

XMedius Solutions Inc.

REGISTERED

Other Marks by Erik Lichter

Additional USPTO filings handled by the same attorney of record.

FXM

FXM RESEARCH

88776470

REGISTERED

FXM

FXM RESEARCH

88776486

REGISTERED

CHA

CHAMILY

97120652

REGISTERED

CHA

CHAMILY

97122680

REGISTERED

FAX PHARMA

Run a conflict check

Other Marks by Fax Pharma Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Erik Lichter

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company